Member News
Happy Clinical Trials Day!
International Clinical Trials Day is held on May 20th each year to commemorate the day that James Lind began the first randomized clinical trial in 1747. Please join Clinical Trials… Read More
Member News
CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine
CanSinoBIO will license in Precision NanoSystems’ proprietary RNA vaccine platform technology Precision NanoSystems will lead RNA vaccine formulation development CanSinoBIO will lead COVID-19 antigen design, pre-clinical testing and clinical trials… Read More
Member News
InMed Pharmaceuticals Continues to Strengthen Biosynthesis Patent Family
Vancouver, BC – May 19, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need… Read More
Member News
Arbutus Announces Single-Dose Week 12 Data in Chronic Hepatitis B Subjects with 60 mg AB-729 Demonstrating a Significant and Continuous Reduction in HBsAg
Mean 60 mg HBsAg reduction of 0.99 log10 IU/mL at week 12, with normal ALT and AST values throughout the follow-up period 90 mg single-dose and 60 mg multi-dose cohorts… Read More
Member News
Neoleukin Therapeutics Announces Multiple Presentations at American Association for Cancer Research (AACR) Virtual Annual Meeting II
Preclinical Data on Lead Immunotherapy Candidate NL-201 Including Immunogencity Results in Non-Human Primates- Novel Conditional Activation Platform Enabled by De Novo Protein Technology Preclinical Results Demonstrate Ability of NL-201 to Expand and… Read More